:format(webp)/cdn.mskdoctors.com/storage/2026/5/FNZ3x8u7DZIxB5FojGh2y3ikNiXwsunr.jpg)
Self-manage or get assessed for hamstring and outer hip painMild hamstring strains can often be managed briefly at home with rest, ice, compression, elevation and gentle movement if walking and basic leg use are still possible. Persistent or worsening outer-hip pain is harder to diagnose and usually needs assessment by a GP, sports medicine or orthopaedic clinician.Mild hamstring strains can often be managed briefly at home with rest, ice, compression, elevation and gentle movement if walking and basic leg use are still possible. Persistent or worsening outer-hip pain is harder to diagnose and usually needs assessment by a GP, sports medicine or orthopaedic clinician.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/m5hussZZ9owL5cSOW8JGtSBbGitjmL5I.jpg)
ChondroFiller repeat injections and long-term repairtissue develops; 81% ofhippatients achieved good ortissue develops; 81% of hip patients achieved good or
:format(webp)/cdn.mskdoctors.com/storage/2026/8/vw5jcuXQi8cORin23JQP7lEfywVPWduD.jpg)
Who treats a TFL strainGluteus medius weakness forces the TFL to compensate; over time, that compensatory overload produces lateralhippain and can lead to IT band syndrome.Gluteus medius weakness forces the TFL to compensate; over time, that compensatory overload produces lateral hip pain and can lead to IT band syndrome.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/ZrxzaoGLN8hdpqCPeFk3Px6MUTnNiwJk.jpg)
Gluteal tendinopathy beyond self-managementa condition in whichhiptendons lose capacity toa condition in which hip tendons lose capacity to
:format(webp)/cdn.mskdoctors.com/storage/2026/5/utVh6k8ZRrTksgxUTh3aGay0CN7PjSyY.jpg)
Choosing PRP or steroid injections for joint painhyaluronic acid in somehipand knee osteoarthritis studies,hyaluronic acid in some hip and knee osteoarthritis studies,
:format(webp)/cdn.mskdoctors.com/storage/2026/6/4czzmfGzWe5uV2nvv4X6hiTJ1Zf1qpJp.jpg)
When joint and muscle injuries need a specialistpulls, shoulder pain andhippain that stall afterpulls, shoulder pain and hip pain that stall after
:format(webp)/cdn.mskdoctors.com/storage/2026/5/OPZyJhwIRk3MeSJkicOCnGlKoCfebyHQ.jpg)
Evaluating newer joint injections against repeat steroid shotsRepeat corticosteroid injections forhipand knee pain easeRepeat corticosteroid injections for hip and knee pain ease
:format(webp)/cdn.mskdoctors.com/storage/2026/8/YhbMqNe7YBZk33LsalLldwHMFTQmXyhT.jpg)
ChondroFiller Injection Evidence Patients Should WeighInjected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/Tc7BZVSZxTAg9ngXUcrH97k20o8iK8T0.jpg)
ChondroFiller injection versus cartilage surgeryChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/S6fB5FURIu0CvCfaH3a2BsSKF1F6KZtW.jpg)
Who qualifies for ChondroFiller Liquid Cartilage injectionChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/rgOU5joVFIvQSkaY3S921m8v6ZjDLgSd.jpg)
Who qualifies for a ChondroFiller injectionChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.ChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/5pdsrZQlBz1P8ijm53n1ADWgRI8gx7rI.jpg)
ChondroFiller Injection Specialists in the UKAcross 19,000+ treated cases worldwide, ChondroFiller has a complication rate of 0.06%; 70–85% of patients with focal cartilage defects achieve meaningful symptom relief over 3–5 years through a collagen scaffold that recruits the patient's own repair cells.Across 19,000+ treated cases worldwide, ChondroFiller has a complication rate of 0.06%; 70–85% of patients with focal cartilage defects achieve meaningful symptom relief over 3–5 years through a collagen scaffold that recruits the patient's own repair cells.
